|
US3891427A
(en)
*
|
1972-10-12 |
1975-06-24 |
Lectromelt Corp |
Method for melting prereduced ore and scrap
|
|
SE378735B
(show.php)
*
|
1972-11-17 |
1975-09-08 |
Asea Ab |
|
|
FR2220584B1
(show.php)
*
|
1973-03-05 |
1976-05-21 |
Siderurgie Fse Inst Rech |
|
|
US3939297A
(en)
*
|
1973-12-07 |
1976-02-17 |
Chase Brass & Copper Co., Incorporated |
Stoker feed system
|
|
SE7503782L
(sv)
*
|
1975-04-02 |
1976-10-03 |
Asea Ab |
Sett och anordning for smeltreduktion av finkornigt jernoxidhaltigt material
|
|
DE2632707C3
(de)
*
|
1976-07-21 |
1983-04-07 |
Ernst Dipl.-Ing. 4006 Erkrath Beiersdorf |
Beschickungsanlage an Elektro-Lichtbogenöfen zur Zugabe von Legierungsmitteln und Zuschlagstoffen
|
|
US4133967A
(en)
*
|
1977-06-24 |
1979-01-09 |
The United States Of America As Represented By The Secretary Of The Interior |
Two-stage electric arc - electroslag process and apparatus for continuous steelmaking
|
|
US4447906A
(en)
*
|
1981-02-02 |
1984-05-08 |
Lectromelt Corporation |
Arc furnace for producing aluminum
|
|
SE8303372L
(sv)
*
|
1983-06-14 |
1984-12-15 |
Asea Ab |
Ugnsanordning for smeltning av metaller eller metallegeringar
|
|
AT384669B
(de)
*
|
1986-03-17 |
1987-12-28 |
Voest Alpine Ag |
Anlage zur herstellung von stahl aus schrott
|
|
CA1311787C
(en)
*
|
1986-06-24 |
1992-12-22 |
Masahisa Tate |
Method of bottom blowing operation of a steel making electric furnace
|
|
FR2705767B1
(fr)
*
|
1993-05-27 |
1995-07-21 |
Lorraine Laminage |
Procédé et installation de production d'acier liquide à partir de matières ferreuses riches en matières carbonées.
|
|
DE4339226A1
(de)
*
|
1993-11-15 |
1995-05-18 |
Mannesmann Ag |
Verfahren und Vorrichtung zur Wertstoffgewinnung
|
|
LU88517A7
(fr)
*
|
1993-12-15 |
1996-02-01 |
Wurth Paul Sa |
Dispositif de chargement d'un four électrique
|
|
AT404841B
(de)
|
1995-04-10 |
1999-03-25 |
Voest Alpine Ind Anlagen |
Anlage und verfahren zum herstellen von eisenschmelzen
|
|
US6673827B1
(en)
|
1999-06-29 |
2004-01-06 |
The Uab Research Foundation |
Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
|
|
US7227011B2
(en)
|
1998-06-04 |
2007-06-05 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Nucleic acid vaccines for prevention of flavivirus infection
|
|
WO2000070285A1
(en)
*
|
1999-05-18 |
2000-11-23 |
Danieli Technology, Inc. |
Electric arc furnace for continuous charging
|
|
EP1702983A3
(en)
|
2000-04-13 |
2007-01-10 |
Medical University of South Carolina |
Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof
|
|
AU2001278875B2
(en)
*
|
2000-07-06 |
2007-06-07 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Tetrahydrobenzothiazole analogues as neuroprotective agents
|
|
US6642002B2
(en)
|
2000-07-17 |
2003-11-04 |
Vanderbilt University |
Method of diagnosing pulmonary hypertension
|
|
EP1326892A2
(en)
|
2000-10-12 |
2003-07-16 |
University of Rochester |
Compositions that inhibit proliferation of cancer cells
|
|
AU2002303277A1
(en)
*
|
2001-04-06 |
2002-10-21 |
Vladimir Larionov |
Artificial chromosomes that can shuttle between bacteria, yeast, and mammalian cells
|
|
JP2005504829A
(ja)
*
|
2001-10-01 |
2005-02-17 |
バンダービルト ユニバーシティ |
構造的心疾患における心筋機能不全を処置するためのカルモジュリンキナーゼｉｉインヒビターの使用
|
|
AU2002332027A1
(en)
*
|
2001-10-04 |
2003-04-14 |
The Government Of The United States Of America, As |
Tandem repeat markers
|
|
JP2005532263A
(ja)
|
2002-02-06 |
2005-10-27 |
ヴァイコー テクノロジーズ， インコーポレイテッド |
抗梗塞分子
|
|
HK1079882B
(en)
|
2002-06-14 |
2011-11-25 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of treating and preventing colitis involving il-13 and nk-t cells
|
|
EP1575992A4
(en)
|
2002-08-05 |
2007-02-21 |
Univ Rochester |
CHEMICAL PROTEINS FROM PROTEIN TRANSDUCATING DOMAIN / DEAMINASE, RELATED COMPOUNDS AND THEIR USES
|
|
WO2004045520A2
(en)
|
2002-11-15 |
2004-06-03 |
Musc Foundation For Research Development |
Complement receptor 2 targeted complement modulators
|
|
EP2410332A1
(en)
|
2002-11-21 |
2012-01-25 |
The University Of Utah |
Method for identifying purinergic modulators of the olfactory system
|
|
EP1711517A4
(en)
|
2004-01-21 |
2008-02-13 |
Univ Utah Res Found |
MUTANT NAv1.7 SODIUM CHANNEL AND ASSOCIATED METHODS
|
|
WO2005086800A2
(en)
|
2004-03-04 |
2005-09-22 |
Vanderbilt University |
Cell-penetrating socs polypeptides that inhibit cytokine-induced signaling
|
|
WO2006016904A2
(en)
*
|
2004-04-14 |
2006-02-16 |
Uab Research Foundation |
Activators of hexosamine biosynthesis as inhibitors of injury induced by ischemia or hemorrhagic shock
|
|
US20050244335A1
(en)
*
|
2004-05-03 |
2005-11-03 |
Rinehart John J |
Methods and compositions related to increasing antitumor activity of chemotherapeutic agents
|
|
JP2007537276A
(ja)
|
2004-05-11 |
2007-12-20 |
ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンティッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ， ナショナル イ |
グレリンを用いて炎症誘発性のサイトカイン発現を阻害する方法
|
|
AU2005326817B2
(en)
|
2004-05-21 |
2012-04-19 |
Benaroya Research Institute |
Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof
|
|
EP1811839A4
(en)
*
|
2004-11-18 |
2008-08-06 |
Univ Rochester |
METHOD AND COMPOSITIONS IN CONNECTION WITH ESCULENTOSIDE A
|
|
JP5243040B2
(ja)
|
2004-12-21 |
2013-07-24 |
ムスク・ファウンデイション・フォー・リサーチ・ディベロップメント |
創傷治癒および組織再生を促進するための組成物および方法
|
|
US9072716B2
(en)
|
2005-04-15 |
2015-07-07 |
The United States of America, as represented by the Secretary Department of Health by Human Servies |
Methods of treating and preventing inflammatory bowel disease involving IL-13 and NKT cells
|
|
WO2006127020A1
(en)
|
2005-05-19 |
2006-11-30 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention |
FUNCTIONAL EPITOPES OF STREPTOCOCCUS PNEUMONIAE PsaA ANTIGEN AND USES THEREOF
|
|
US8859585B2
(en)
*
|
2005-05-25 |
2014-10-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Scopolamine for the treatment of depression and anxiety
|
|
DK2468847T3
(en)
|
2005-06-07 |
2017-06-06 |
Dsm Nutritional Products Ag |
EUCARYOTIC MICRO-ORGANISMS FOR THE PREPARATION OF LIPIDS AND ANTIOXIDANTS
|
|
US8080534B2
(en)
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
|
EP1934331A4
(en)
|
2005-10-14 |
2009-01-21 |
Musc Found For Res Dev |
TARGETING PAX2 TO INDUCE CANCER TREATMENT AND TUMOR IMMUNITY INDUCED BY DEFB1
|
|
ES2594607T3
(es)
|
2005-12-29 |
2016-12-21 |
The Regents Of The University Of California |
Procedimientos y composiciones relacionadas con el dominio Kunitz I mutante de TFPI-2
|
|
WO2007081792A2
(en)
|
2006-01-05 |
2007-07-19 |
University Of Utah Research Foundation |
Methods and compositions related to improving properties of pharmacological agents targeting nervous system
|
|
CA2638911C
(en)
|
2006-02-06 |
2018-01-23 |
Burnham Institute For Medical Research |
Methods and compositions related to targeting tumors and wounds
|
|
AU2007223427A1
(en)
*
|
2006-03-01 |
2007-09-13 |
University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
|
US8470965B2
(en)
*
|
2006-03-01 |
2013-06-25 |
University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
|
CA2644338A1
(en)
|
2006-03-02 |
2007-09-07 |
The Uab Research Foundation |
Mycobacterial disease detection, treatment, and drug discovery
|
|
CA2657256C
(en)
|
2006-07-10 |
2015-04-07 |
Synapsin Pharmaceuticals, Inc. |
Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing cognitive and physical performance
|
|
NZ574473A
(en)
|
2006-08-02 |
2013-02-22 |
Uab Research Foundation |
Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity
|
|
EP3034083B1
(en)
|
2006-09-21 |
2020-12-09 |
University of Rochester |
Antisense oligonucleotides for use in treating myotonic dystrophy
|
|
WO2008136852A2
(en)
|
2006-11-01 |
2008-11-13 |
University Of Rochester |
Methods and compositions related to the structure and function of apobec3g
|
|
EP2104509A4
(en)
|
2006-12-11 |
2010-03-24 |
Univ Utah Res Found |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL ANGIOGENESIS AND VASPERMEABILITY
|
|
US20120030779A1
(en)
|
2007-01-18 |
2012-02-02 |
University Of Utah Research Foundtion |
Compositions and methods for detecting, treating, or preventing reductive stress
|
|
CA2677665C
(en)
|
2007-02-08 |
2019-11-05 |
University Of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
|
AU2008227458A1
(en)
|
2007-03-22 |
2008-09-25 |
Yale University |
Methods and compositions related to riboswitches that control alternative splicing
|
|
EP2433496A1
(en)
|
2007-05-08 |
2012-03-28 |
Burnham Institute for Medical Research |
Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
|
|
CA2687024A1
(en)
|
2007-05-09 |
2009-02-19 |
Burnham Institute For Medical Research |
Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
|
|
US8329195B2
(en)
|
2007-05-23 |
2012-12-11 |
The Uab Research Foundation |
Detoxified pneumococcal neuraminidase and uses thereof
|
|
MX2009012773A
(es)
|
2007-05-29 |
2009-12-16 |
Univ Yale |
Ribointerruptores y metodos y composiciones para usarse de y con ribointerruptores.
|
|
EP2166845B1
(en)
|
2007-06-21 |
2015-10-21 |
Musc Foundation for Research Development |
Alpha connexin c-terminal (act) peptides for treating age-related macular degeneration
|
|
US20110081317A1
(en)
*
|
2007-08-08 |
2011-04-07 |
University Of Rochester |
Enhancing Gene Transfer
|
|
TW200916113A
(en)
|
2007-08-08 |
2009-04-16 |
Sod Conseils Rech Applic |
Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
|
|
WO2009042294A2
(en)
*
|
2007-08-10 |
2009-04-02 |
Burnham Institute For Medical Research |
Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof
|
|
EP2268664B1
(en)
|
2007-12-03 |
2017-05-24 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Doc1 compositions and methods for treating cancer
|
|
US20090233993A1
(en)
*
|
2008-03-06 |
2009-09-17 |
Burnham Institute For Medical Research |
Compositions and methods for inhibiting gsk3 activity and uses thereof
|
|
US20110262395A1
(en)
|
2008-05-08 |
2011-10-27 |
University Of Utah Research Foundation |
Sensory receptors for chronic fatigue and pain and uses thereof
|
|
US20090291073A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Ward Keith W |
Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
|
|
US8816095B2
(en)
*
|
2008-08-15 |
2014-08-26 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
|
WO2010065617A1
(en)
|
2008-12-02 |
2010-06-10 |
University Of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
|
US20100286762A1
(en)
*
|
2009-03-18 |
2010-11-11 |
Musc Foundation For Research Development |
Compositions and Methods for Ameliorating Clinical Electrical Disturbances
|
|
US20120107331A1
(en)
|
2009-05-15 |
2012-05-03 |
Yale University |
Gemm riboswitches, structure-based compound design with gemm riboswitches, and methods and compositions for use of and with gemm riboswitches
|
|
WO2011020107A2
(en)
|
2009-08-14 |
2011-02-17 |
Georgetown University |
Compositions and methods for detection and treatment of breast cancer
|
|
WO2011022502A1
(en)
|
2009-08-18 |
2011-02-24 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
|
US20110060000A1
(en)
|
2009-09-10 |
2011-03-10 |
Maurizio Grimaldi |
Acridine analogs in the treatment of gliomas
|
|
US20120321647A1
(en)
|
2010-01-12 |
2012-12-20 |
Yale University |
Structured rna motifs and compounds and methods for their use
|
|
US20130045181A1
(en)
|
2010-03-09 |
2013-02-21 |
Guangming Zhong |
Methods and Compositions for Chlamydial Antigens for Diagnosis and Treatment of Chlamydial Infection and Disease
|
|
EP2555802A1
(en)
|
2010-04-08 |
2013-02-13 |
Sanford-Burnham Medical Research Institute |
Methods and compositions for enhanced delivery of compounds
|
|
WO2012021554A1
(en)
|
2010-08-09 |
2012-02-16 |
Yale University |
Cyclic di-gmp-ii riboswitches, motifs, and compounds, and methods for their use
|
|
US20130324467A1
(en)
|
2010-12-15 |
2013-12-05 |
Neuroadjuvants, Inc |
Neuropeptide analogs, compositions, and methods for treating pain
|
|
CN103841991B
(zh)
|
2011-03-15 |
2018-03-27 |
犹他大学研究基金会 |
诊断和治疗血管相关黄斑病及其症状的方法
|
|
EP2691105B1
(en)
|
2011-03-28 |
2018-07-11 |
University of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
|
US10766937B2
(en)
|
2011-09-06 |
2020-09-08 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods of treating cancer
|
|
US9732144B2
(en)
|
2012-07-05 |
2017-08-15 |
Ohio State Innovation Foundation |
Infectious bursal disease (IBDV) vaccine compositions
|
|
WO2014141111A1
(en)
|
2013-03-14 |
2014-09-18 |
Pluristem Ltd. |
Methods for prevention and treatment of graft-versus-host disease
|
|
WO2014201118A2
(en)
|
2013-06-11 |
2014-12-18 |
Sanford-Burnham Medical Research Institute |
Compositions and methods for targeted endometriosis treatment
|
|
EP3711484A1
(en)
|
2013-07-05 |
2020-09-23 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Soluble cd33 for treating myelodysplastic syndromes (mds)
|
|
WO2015143335A1
(en)
|
2014-03-20 |
2015-09-24 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for chimeric coronavirus spike proteins
|
|
WO2016049380A1
(en)
|
2014-09-24 |
2016-03-31 |
University Of Utah Research Foundation |
Ebolavirus pre-hairpin intermediate mimics and methods of use
|
|
JP2018504141A
(ja)
|
2015-01-20 |
2018-02-15 |
アドキュア バイオテクノロジーズ、 エルエルシー |
非標的化アデノウイルス変異体および関連する方法
|
|
EP3258961A4
(en)
|
2015-02-20 |
2018-08-22 |
Board of Regents, The University of Texas System |
Methods and compositions for attenuated chlamydia as vaccine and vector
|
|
US10765754B2
(en)
|
2015-08-28 |
2020-09-08 |
Navigen, Inc. |
Compositions and methods related to inhibition of respiratory syncytial virus entry
|
|
CN109069577B
(zh)
|
2016-01-07 |
2022-08-19 |
纳维根公司 |
Hiv进入的d-肽抑制剂以及使用方法
|
|
US11492397B2
(en)
|
2016-03-16 |
2022-11-08 |
Abeome Corporation |
Neutralizing monoclonal antibodies to IL-25 and uses thereof
|
|
US10751340B2
(en)
|
2016-06-06 |
2020-08-25 |
University Of Central Florida Research Foundation, Inc. |
Combination therapy to improve brain function or promote neurogenesis for treating neurodegenerative conditions
|
|
CN110087662A
(zh)
|
2016-07-29 |
2019-08-02 |
俄亥俄州国家创新基金会 |
用溶瘤病毒表达pten-long
|
|
AU2017340633B2
(en)
|
2016-10-05 |
2024-01-11 |
University Of Central Florida Research Foundation, Inc. |
Methods and compositions related to NK cell and anti-PDL1 cancer therapies
|
|
CA3057211A1
(en)
|
2017-02-28 |
2018-09-07 |
University Of Central Florida Research Foundation, Inc. |
Pm21 particles to improve bone marrow homing of nk cells
|
|
EP4215201A1
(en)
|
2017-03-24 |
2023-07-26 |
Ohio State Innovation Foundation |
Novel recombinant adeno-associated viral vectors restricting off-target transduction in liver and uses thereof
|
|
CA3058393A1
(en)
|
2017-03-28 |
2018-10-04 |
Ohio State Innovation Foundation |
Human pd1 peptide vaccines and uses thereof
|
|
US20230140818A1
(en)
|
2017-04-27 |
2023-05-04 |
The University Of Hong Kong |
Use of hcn inhibitors for treatment of cancer
|
|
JP7522426B2
(ja)
|
2017-05-25 |
2024-07-25 |
ユニバーシティ オブ セントラル フロリダ リサーチ ファウンデーション，インコーポレイテッド |
天然キラー細胞による殺傷に対する腫瘍細胞の感受性を高めるための新規な腫瘍溶解性ウイルス
|
|
WO2019067403A2
(en)
|
2017-09-26 |
2019-04-04 |
Sanford Burnham Prebys Medical Discovery Institute |
COMPOSITIONS AND METHODS FOR EVALUATION OF PAINFUL DEMYELINIZING AND NON-DEMYELING DISEASES
|
|
EP3723770A4
(en)
|
2017-12-13 |
2021-11-24 |
North Carolina State University |
COMPOSITIONS INCLUDING CHEMOTHERAPEUTIC AGENTS AND CHECKPOINT INHIBITORS AND METHODS OF USE
|
|
US12161720B2
(en)
|
2018-04-06 |
2024-12-10 |
North Carolina State University |
Cell assembly-mediated delivery of checkpoint inhibitors for cancer immunotherapy
|
|
US11717551B2
(en)
|
2018-05-07 |
2023-08-08 |
Georgia State University Research Foundation, Inc. |
Compositions and methods related to Rhamnus prinoides (GESHO) extract for the inhibition of polymicrobial biofilm formation
|
|
IL278723B2
(en)
|
2018-05-16 |
2024-07-01 |
Res Inst Nationwide Childrens Hospital |
Generation of knock-out primary and expanded human nk cells using cas9 ribonucleoproteins
|
|
EP3801028A4
(en)
|
2018-05-30 |
2022-04-13 |
Direct Biologics LLC |
A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use
|
|
WO2020006493A1
(en)
|
2018-06-29 |
2020-01-02 |
North Carolina State University |
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical treatment
|
|
US11331269B2
(en)
|
2018-09-06 |
2022-05-17 |
Massachusetts Institute Of Technology |
Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment
|
|
EP3847650A1
(en)
|
2018-09-06 |
2021-07-14 |
The Broad Institute, Inc. |
Nucleic acid assemblies for use in targeted delivery
|
|
EP3861024A4
(en)
|
2018-10-03 |
2022-12-21 |
University of Pittsburgh - of the Commonwealth System of Higher Education |
COVALENT ADAPTOR-SYNNOTCH AND CHIMERIC ANTIGEN RECEPTORS (CARS) FOR PROGRAMMABLE ANTIGEN TARGETING
|
|
WO2020092057A1
(en)
|
2018-10-30 |
2020-05-07 |
Yale University |
Compositions and methods for rapid and modular generation of chimeric antigen receptor t cells
|
|
US12202867B2
(en)
|
2018-11-02 |
2025-01-21 |
The Johns Hopkins University |
Adeno-associated viral chimeric TDP-43 proteins
|
|
US20220136064A1
(en)
|
2019-02-09 |
2022-05-05 |
King Abdullah University Of Science And Technology |
Compositions and methods for cancer diagnosis and prognosis
|
|
WO2020257640A1
(en)
|
2019-06-21 |
2020-12-24 |
Vaccinex, Inc. |
Combination therapy with semaphorin-4d blockade (sema4d) and dc1 therapy
|
|
AU2020315475A1
(en)
|
2019-07-18 |
2022-02-03 |
Direct Biologics Llc |
Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
|
|
MX2022005051A
(es)
|
2019-10-31 |
2022-08-08 |
Res Inst Nationwide Childrens Hospital |
Generación de células nk humanas primarias y expandidas con inactivacion de cd38.
|
|
WO2021211749A1
(en)
|
2020-04-14 |
2021-10-21 |
The Regents Of The University Of California |
Multi-epitope pan-coronavirus vaccine compositions
|
|
US11225508B1
(en)
|
2020-09-23 |
2022-01-18 |
The University Of North Carolina At Chapel Hill |
Mouse-adapted SARS-CoV-2 viruses and methods of use thereof
|
|
JP2023554589A
(ja)
|
2020-11-27 |
2023-12-28 |
ジェネラル ナノセラピューティクス エルエルシー |
免疫媒介性疾患の治療のための方法及び組成物
|
|
US20230279442A1
(en)
|
2021-12-15 |
2023-09-07 |
Versitech Limited |
Engineered cas9-nucleases and method of use thereof
|
|
KR102436232B1
(ko)
*
|
2022-01-17 |
2022-08-25 |
주식회사 세명하이트 |
원통형 필터 제조방법 및 이에 따라 제조된 원통형 필터
|
|
US20250228940A1
(en)
|
2022-03-11 |
2025-07-17 |
Yale University |
Compositions and methods for efficient and stable genetic modification of eukaryotic cells
|
|
WO2023220644A1
(en)
|
2022-05-10 |
2023-11-16 |
Yale University |
Compositions and methods of synthetic ctla-4 tails for reprogramming of car-t cells and enhancement of anti-tumor efficacy
|
|
KR102736561B1
(ko)
*
|
2022-06-03 |
2024-12-02 |
현대제철 주식회사 |
전기로
|
|
KR102751454B1
(ko)
*
|
2022-06-03 |
2025-01-10 |
현대제철 주식회사 |
전기로
|
|
KR102829902B1
(ko)
*
|
2022-07-29 |
2025-07-04 |
현대제철 주식회사 |
전기로
|
|
KR102777625B1
(ko)
*
|
2022-07-29 |
2025-03-11 |
현대제철 주식회사 |
전기로
|
|
KR102793154B1
(ko)
*
|
2022-08-26 |
2025-04-07 |
현대제철 주식회사 |
전기로
|
|
KR102752443B1
(ko)
*
|
2022-08-26 |
2025-01-09 |
현대제철 주식회사 |
전기로
|
|
WO2024064824A2
(en)
|
2022-09-21 |
2024-03-28 |
Yale University |
Compositions and methods for identification of membrane targets for enhancement of nk cell therapy
|
|
WO2024102997A1
(en)
|
2022-11-11 |
2024-05-16 |
Peterson Jeff R |
Gout flare prevention methods using il-1β inhibitors
|
|
KR102799788B1
(ko)
*
|
2022-11-29 |
2025-04-22 |
현대제철 주식회사 |
전기로용 저취교반장치 및 이를 포함하는 전기로
|
|
WO2024155821A1
(en)
|
2023-01-18 |
2024-07-25 |
Yale University |
Chimeric antigen receptors (car) with intrinsically disordered regions and methods of use thereof
|
|
WO2024226829A2
(en)
|
2023-04-26 |
2024-10-31 |
Yale University |
Enpp3-binding molecules, compositions formed therefrom, and methods of use thereof for the treatment of cancer
|
|
WO2024238656A1
(en)
|
2023-05-15 |
2024-11-21 |
Yale Univeristy |
Chimeric antigen receptor compositions, car-mast cells formed therefrom, and methods of use thereof
|
|
US12269875B2
(en)
|
2023-08-03 |
2025-04-08 |
Jeff R. Peterson |
Gout flare prevention methods using IL-1BETA blockers
|
|
WO2025158400A1
(en)
|
2024-01-24 |
2025-07-31 |
Yale University |
Compositions and methods of natural killer cell hyperboosts for enhancement of nk cell therapy
|
|
US12502407B2
(en)
|
2024-04-25 |
2025-12-23 |
Direct Biologics, Llc |
Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles
|
|
WO2025264861A1
(en)
|
2024-06-18 |
2025-12-26 |
Yale University |
Compositions of bi-functional alpha helical peptides and methods thereof for treating tdp-43 proteinopathies
|
|
WO2026006542A2
(en)
|
2024-06-26 |
2026-01-02 |
Yale University |
Compositions and methods for crispr/cas9 based reactivation of human angelman syndrome
|